• OPEN AN ACCOUNT
Indian Indices
Nifty
25,959.50 -108.65
(-0.42%)
Sensex
84,900.71 -331.21
( -0.39%)
Bank Nifty
58,835.35 -32.35
( -0.05%)
Nifty IT
37,037.95 152.60
( 0.41%)
Global Indices
Nasdaq
46,275.21 501.96
(1.10%)
Dow Jones
6,624.30 64.54
(0.98%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,569.96 30.25
(0.32%)
Forex
USD-INR
88.67 0.16
(0.19%)
EUR-INR
102.19 -0.14
(-0.14%)
GBP-INR
115.88 -0.12
(-0.10%)
JPY-INR
0.56 0.00
(-0.65%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
205.5515954
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
41.47
819.05
EPS(TTM)
Face Value()
Div & Yield %
16.76
10
0.11
 

national st&ard (india) ltd
Vistar Amar Ltd - Closure of Trading Window
Jun 27,2025
The Trading Window for dealing in Companys securities shall be closed for Designated Persons and their immediate relative(s) w.e.f. 1st July 2025 till the end of 48 hours after the declaration of Financial Results for the quarter ended 30th June 2025 in terms of SEBI (Prohibition of Insider Trading) Regulation 2015 and Companys Code of Conduct to regulate monitor and report trading by Designated Persons and immediate relatives of Designated Persons. The date of Board Meeting for declaration of the Financial Results of the Company for the quarter ended 30th June 2025 will be intimated in due course.